The Antidiabetic Drug Lobeglitazone Protects Mice From Lipogenesis-Induced Liver Injury via Mechanistic Target of Rapamycin Complex 1 Inhibition

Overview of attention for article published in Frontiers in endocrinology, September 2018

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 12 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 10,856 followers.

The antidiabetic drug lobeglitazone protects mice from lipogenesis-induced liver injury via mTORC1 inhibition #diabetes #NAFLD @FrontEndocrinol https://t.co/kcjz7Pws34

10 Oct 2018

Reply Repost Favourite

The Antidiabetic Drug Lobeglitazone Protects Mice From Lipogenesis-Induced Liver Injury via Mechanistic Target of Rapamycin Complex 1 Inhibition: Yu Seol Lee, Jeong Su Park, Da Hyun Lee, Dong-Kyu Lee, Sung Won Kwon, Byung-Wan Lee, Soo Han Bae https://t.co/

22 Sep 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.